Trials / Conditions / Acute Lymphobkastic Leukemia

Acute Lymphobkastic Leukemia

10 registered clinical trials studyying Acute Lymphobkastic Leukemia — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Immunotherapy Combined With Auto-HSCT and CD22/CD19 CAR-T Sandwich Strategy for B-ALL NCT06985498	The First Affiliated Hospital of Soochow University	Phase 2
Not Yet Recruiting	A Phase 1/2 Study of T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With C NCT07503353	Sheba Medical Center	Phase 1 / Phase 2
Not Yet Recruiting	Evaluation of the Efficacy of Ponatinib in Ph+ ALL in the Real-world NCT07356960	Gruppo Italiano Malattie EMatologiche dell'Adulto	—
Not Yet Recruiting	This is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy o NCT07162571	Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology	Phase 1 / Phase 2
Not Yet Recruiting	To Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of STR-P004 NCT07245251	Starna Therapeutics	N/A
Recruiting	Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia NCT07258043	Hospital General de Mexico	—
Recruiting	Efficacy of Low-dose Venetoclax With Itraconazole + TACL for R/R ALL Patients NCT07039877	Hospital Universitario Dr. Jose E. Gonzalez	Phase 2
Completed	Optimizing Recovery in Pediatric ALL Survivors: A Training Comparison NCT07330141	Cairo University	N/A
Recruiting	A Study to Determine Number of Patients Who Develop High Ammonia Levels After Receiving Recombinant Erwinia As NCT06600659	Mayo Clinic	—
Completed	Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia NCT02036489	PETHEMA Foundation	Phase 4